New risk score could predict survival in lung disease patients

NCT ID NCT07151768

Recruiting now Diagnosis Sponsor: Temple University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing whether a new risk score called PVD-B65 can accurately predict who will survive for one year after being diagnosed with pulmonary hypertension related to chronic lung disease. Researchers will follow 100 adults and track deaths and other health changes. The score uses information from standard tests, so no extra procedures are needed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this risk score could help doctors better identify patients who need more aggressive monitoring or treatment.
What could go wrong: This is an early observational study with only 100 participants. The score may not work as well in a broader group, and it does not test any new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease pulmonary hypertension pulmonary hypertension owing to lung disease and/or hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LUNG DISEASE PULMONARY HYPERTENSION

Contacts and locations

Locations

Temple University Hospital
RECRUITING

Philadelphia, Pennsylvania, 19140, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.